In which scenarios do you use vaginal estrogen in patients with history of HR positive breast cancer?
Do you feel differently about using these in patients with a history of HR-negative breast cancer?
Answer from: Medical Oncologist at Academic Institution
A recent study (McVicker et al., PMID 37917089) supports the likely safety of vaginal estrogens in breast cancer survivors. Limitations of this study are that it primarily included lower-risk individuals with stage I-II disease and women 50+. In addition, the level of data is limited by the retrospe...